Veralox Therapeutics Company

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Industry: Early Drug Development
Headquarters: Frederick, Maryland, United States
Founded Date: 2017-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 14
Total Funding: 22000000
Estimated Revenue: Less than $1M
Last Funding Date: 2021-06-16
Last Funding Type: Series A

Visit Website
Register and Claim Ownership